4//SEC Filing
HAYDEN BRIAN J 4
Accession 0000950117-09-000228
CIK 0000722104other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 5:20 PM ET
Size
5.2 KB
Accession
0000950117-09-000228
Insider Transaction Report
Form 4
HAYDEN BRIAN J
SVP, Chief Financial Officer
Transactions
- Sale
Common Stopck, $.01 par value per share
2009-02-17$5.77/sh−3,441$19,840→ 11,445 total
Footnotes (1)
- [F1]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 15, 2007.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeother
Related Parties
1- filerCIK 0001262224
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 5:20 PM ET
- Size
- 5.2 KB